TANG CAPITAL MANAGEMENT LLC
CIK 1232621 · last filed 2026-10-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ODT price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUITE 210
SAN DIEGO, CA 92121
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BOLD | 10%+ Owner | 2,958,820 | $2.41 | $7.13M | $3.73M | 7 | 2026-10-20 |
| FULC | 10%+ Owner | 7,030,000 | $3.67 | $25.80M | $2.97M | 2 | 2026-07-20 |
| AUPH | 10%+ Owner | 12,838,002 | $17.05 | $218.89M | $24.91M | 1 | 2026-06-02 |
| TCR2 THERAPEUTICS INC. (TCRR) Delisted | 10%+ Owner | 4,394,800 | $1.48 | $6.50M | $1.90M | 2 | 2023-05-30 |
| Odonate Therapeutics, Inc. (ODT) Delisted | 10%+ Owner | 15,045,717 | $1.12 | $16.85M | $77.61M | 7 | 2021-11-19 |
| LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | 10%+ Owner | 9,194,673 | $6.22 | $57.19M | $41.28M | 7 | 2020-09-09 |
| Bio Green Med Solution, Inc. (CYCCP) Delisted | 10%+ Owner | 559,900 | $5.05 | $2.83M | $1.75M | 1 | 2017-02-27 |
| Ardea Biosciences, Inc./DE (RDEA) Delisted | 10%+ Owner | 3,748,671 | — | — | $21.75M | 2 | 2012-02-03 |
| HERON THERAPEUTICS, INC. /DE/ (APPA) Delisted | 10%+ Owner | 16,496 | — | — | $10.71M | 5 | 2009-10-21 |
| VNDA | 10%+ Owner | 3,065,852 | $3.96 | $12.14M | -$20.62M | 4 | 2009-10-15 |
| PENWEST PHARMACEUTICALS CO (PPCO) Delisted | 10%+ Owner | 6,392,498 | — | — | $204.4K | 2 | 2009-03-13 |
| ARADIGM CORP (ARDM) Delisted | 10%+ Owner | 13,500 | — | — | $0 | 1 | 2008-11-12 |
| NEOSE TECHNOLOGIES INC (NTEC) Delisted | 10%+ Owner | 512,596 | $9.63 | $4.94M | $951.9K | 2 | 2008-09-24 |
| Molecular Templates, Inc. (THLDD) Delisted | 10%+ Owner | 54,231 | — | — | $4.50M | 1 | 2008-09-03 |
| TAPESTRY PHARMACEUTICALS, INC (TPPH) Delisted | 10%+ Owner | 1,118,047 | — | — | -$269.3K | 1 | 2008-02-20 |
Recent Filings · Page 6 of 6
54 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2008-04-28 | — | Buy (P) | +1,140,000 | $2.05M | |
| 2008-04-24 | HERON THERAPEUTICS, INC. /DE/ (APPA) Delisted | Buy (P) | +2,088,216 | $2.09M | EDGAR |
| 2008-04-07 | — | Buy (P) | +810,000 | $1.49M | |
| 2008-02-20 | TAPESTRY PHARMACEUTICALS, INC (TPPH) Delisted | Sell (S) | −2,907,258 | -$269.3K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.